enGene Therapeutics (S0N0.F) Q1 2026 Earnings

9MarConfirmed
Q1 2026
-0.48
-0.45
-0.41
-0.38

Details

Expected EPS
-0.48133046826000003
Actual EPS
-0.3784572
Surprise EPS
0.1
Surprise Percent
+21.37%

Description

enGene Therapeutics (S0N0.F) has reported earnings of -0.3784572 per share for Q1 2026.

0 Comments

Share your thoughts